Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bolla

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991Michel Bolla, Philippe Maingon, Christian Carrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2026
Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trialsJosien C C Scheepens, Luigi Lim, Jammbe Z Musoro, et al.
Molecular Cell|April 7, 2018
Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal SiteLucile Pantel, Tanja Florin, Malgorzata Dobosz-Bartoszek, et al.
European Urology|December 23, 2015
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic ReviewRoderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, et al.
European Urology|August 30, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|August 1, 2017
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewMichael Lardas, Matthew Liew, Roderick C van den Bergh, et al.
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
European Urology|March 25, 2017
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines PanelPaul C Moldovan, Thomas Van den Broeck, Richard Sylvester, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991Michel Bolla, Philippe Maingon, Christian Carrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk DiseaseMichel Bolla, Anouk Neven, Philippe Maingon, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2026
Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trialsJosien C C Scheepens, Luigi Lim, Jammbe Z Musoro, et al.
Molecular Cell|April 7, 2018
Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal SiteLucile Pantel, Tanja Florin, Malgorzata Dobosz-Bartoszek, et al.
European Urology|December 23, 2015
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic ReviewRoderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, et al.
European Urology|August 30, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|August 1, 2017
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewMichael Lardas, Matthew Liew, Roderick C van den Bergh, et al.
European Urology|January 28, 2017
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic ReviewNicola Fossati, Peter-Paul M Willemse, Thomas Van den Broeck, et al.
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
European Urology|March 25, 2017
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines PanelPaul C Moldovan, Thomas Van den Broeck, Richard Sylvester, et al.
Pageof 16